Deep sequencing revealed skewed predominance of a single T cell clone, representing >90% of CAR T cells, which was not detectable in the pre-infusion product and was subsequently found to harbour a SIN-LV insertion into the methylcytosine dioxygenase TET2 gene site, a known tumour suppressor gene. This evidence concerns the gene TET2 and neoplasm.